Mitochondrial oxidative metabolism and uncoupling proteins in the failing heart

Verfasser / Beitragende:
[Alexander Akhmedov, Vitalyi Rybin, José Marín-García]
Ort, Verlag, Jahr:
2015
Enthalten in:
Heart Failure Reviews, 20/2(2015-03-01), 227-249
Format:
Artikel (online)
ID: 605479151
LEADER caa a22 4500
001 605479151
003 CHVBK
005 20210128100408.0
007 cr unu---uuuuu
008 210128e20150301xx s 000 0 eng
024 7 0 |a 10.1007/s10741-014-9457-4  |2 doi 
035 |a (NATIONALLICENCE)springer-10.1007/s10741-014-9457-4 
245 0 0 |a Mitochondrial oxidative metabolism and uncoupling proteins in the failing heart  |h [Elektronische Daten]  |c [Alexander Akhmedov, Vitalyi Rybin, José Marín-García] 
520 3 |a Despite significant progress in cardiovascular medicine, myocardial ischemia and infarction, progressing eventually to the final end point heart failure (HF), remain the leading cause of morbidity and mortality in the USA. HF is a complex syndrome that results from any structural or functional impairment in ventricular filling or blood ejection. Ultimately, the heart's inability to supply the body's tissues with enough blood may lead to death. Mechanistically, the hallmarks of the failing heart include abnormal energy metabolism, increased production of reactive oxygen species (ROS) and defects in excitation-contraction coupling. HF is a highly dynamic pathological process, and observed alterations in cardiac metabolism and function depend on the disease progression. In the early stages, cardiac remodeling characterized by normal or slightly increased fatty acid (FA) oxidation plays a compensatory, cardioprotective role. However, upon progression of HF, FA oxidation and mitochondrial oxidative activity are decreased, resulting in a significant drop in cardiac ATP levels. In HF, as a compensatory response to decreased oxidative metabolism, glucose uptake and glycolysis are upregulated, but this upregulation is not sufficient to compensate for a drop in ATP production. Elevated mitochondrial ROS generation and ROS-mediated damage, when they overwhelm the cellular antioxidant defense system, induce heart injury and contribute to the progression of HF. Mitochondrial uncoupling proteins (UCPs), which promote proton leak across the inner mitochondrial membrane, have emerged as essential regulators of mitochondrial membrane potential, respiratory activity and ROS generation. Although the physiological role of UCP2 and UCP3, expressed in the heart, has not been clearly established, increasing evidence suggests that these proteins by promoting mild uncoupling could reduce mitochondrial ROS generation and cardiomyocyte apoptosis and ameliorate thereby myocardial function. Further investigation on the alterations in cardiac UCP activity and regulation will advance our understanding of their physiological roles in the healthy and diseased heart and also may facilitate the development of novel and more efficient therapies. 
540 |a Springer Science+Business Media New York, 2014 
690 7 |a Heart failure  |2 nationallicence 
690 7 |a Energy metabolism  |2 nationallicence 
690 7 |a Mitochondria  |2 nationallicence 
690 7 |a Reactive oxygen species  |2 nationallicence 
690 7 |a Proton leak  |2 nationallicence 
690 7 |a Uncoupling proteins  |2 nationallicence 
700 1 |a Akhmedov  |D Alexander  |u The Molecular Cardiology and Neuromuscular Institute, 75 Raritan Avenue, 08904, Highland Park, NJ, USA  |4 aut 
700 1 |a Rybin  |D Vitalyi  |u The Molecular Cardiology and Neuromuscular Institute, 75 Raritan Avenue, 08904, Highland Park, NJ, USA  |4 aut 
700 1 |a Marín-García  |D José  |u The Molecular Cardiology and Neuromuscular Institute, 75 Raritan Avenue, 08904, Highland Park, NJ, USA  |4 aut 
773 0 |t Heart Failure Reviews  |d Springer US; http://www.springer-ny.com  |g 20/2(2015-03-01), 227-249  |x 1382-4147  |q 20:2<227  |1 2015  |2 20  |o 10741 
856 4 0 |u https://doi.org/10.1007/s10741-014-9457-4  |q text/html  |z Onlinezugriff via DOI 
898 |a BK010053  |b XK010053  |c XK010000 
900 7 |a Metadata rights reserved  |b Springer special CC-BY-NC licence  |2 nationallicence 
908 |D 1  |a research-article  |2 jats 
949 |B NATIONALLICENCE  |F NATIONALLICENCE  |b NL-springer 
950 |B NATIONALLICENCE  |P 856  |E 40  |u https://doi.org/10.1007/s10741-014-9457-4  |q text/html  |z Onlinezugriff via DOI 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a Akhmedov  |D Alexander  |u The Molecular Cardiology and Neuromuscular Institute, 75 Raritan Avenue, 08904, Highland Park, NJ, USA  |4 aut 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a Rybin  |D Vitalyi  |u The Molecular Cardiology and Neuromuscular Institute, 75 Raritan Avenue, 08904, Highland Park, NJ, USA  |4 aut 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a Marín-García  |D José  |u The Molecular Cardiology and Neuromuscular Institute, 75 Raritan Avenue, 08904, Highland Park, NJ, USA  |4 aut 
950 |B NATIONALLICENCE  |P 773  |E 0-  |t Heart Failure Reviews  |d Springer US; http://www.springer-ny.com  |g 20/2(2015-03-01), 227-249  |x 1382-4147  |q 20:2<227  |1 2015  |2 20  |o 10741